Antibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17692-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17692-1-AP, RRID:AB_2146624
- Product name
- MYOM3 antibody
- Antibody type
- Polyclonal
- Description
- MYOM3 antibody (Cat. #17692-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III.
Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides.
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy.
Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice.
Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy.
Changes in Urinary Titin Fragment in Response to Different Types of Dynamic Eccentric Exercises.
An acute eccentric exercise increases circulating myomesin 3 fragments.
Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice.
A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology.
Mutant myocilin impacts sarcomere ultrastructure in mouse gastrocnemius muscle.
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.
Gardin A, Rouillon J, Montalvo-Romeral V, Rossiaud L, Vidal P, Launay R, Vie M, Krimi Benchekroun Y, Cosette J, Bertin B, La Bella T, Dubreuil G, Nozi J, Jauze L, Fragnoud R, Daniele N, Van Wittenberghe L, Esque J, André I, Nissan X, Hoch L, Ronzitti G
The Journal of clinical investigation 2024 Jan 16;134(2)
The Journal of clinical investigation 2024 Jan 16;134(2)
Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides.
Relizani K, Echevarría L, Zarrouki F, Gastaldi C, Dambrune C, Aupy P, Haeberli A, Komisarski M, Tensorer T, Larcher T, Svinartchouk F, Vaillend C, Garcia L, Goyenvalle A
Nucleic acids research 2022 Jan 11;50(1):17-34
Nucleic acids research 2022 Jan 11;50(1):17-34
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy.
Bourg N, Vu Hong A, Lostal W, Jaber A, Guerchet N, Tanniou G, Bordier F, Bertil-Froidevaux E, Georger C, Daniele N, Richard I, Israeli D
International journal of molecular sciences 2022 Feb 11;23(4)
International journal of molecular sciences 2022 Feb 11;23(4)
Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice.
Bizot F, Goossens R, Tensorer T, Dmitriev S, Garcia L, Aartsma-Rus A, Spitali P, Goyenvalle A
Molecular therapy. Nucleic acids 2022 Dec 13;30:606-620
Molecular therapy. Nucleic acids 2022 Dec 13;30:606-620
Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy.
Riddell DO, Hildyard JCW, Harron RCM, Wells DJ, Piercy RJ
Wellcome open research 2021;6:354
Wellcome open research 2021;6:354
Changes in Urinary Titin Fragment in Response to Different Types of Dynamic Eccentric Exercises.
Lee M, Goral K, Flis D, Skrobot W, Cieminski K, Olek R, Akimoto T, Ziolkowski W
International journal of sports medicine 2021 May;42(5):432-440
International journal of sports medicine 2021 May;42(5):432-440
An acute eccentric exercise increases circulating myomesin 3 fragments.
Lee M, Shin J, Kato T, Kanda K, Oikawa S, Sakuma J, Sugama K, Kawakami Y, Suzuki K, Akimoto T
The journal of physiological sciences : JPS 2021 Jan 19;71(1):4
The journal of physiological sciences : JPS 2021 Jan 19;71(1):4
Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice.
Aupy P, Zarrouki F, Sandro Q, Gastaldi C, Buclez PO, Mamchaoui K, Garcia L, Vaillend C, Goyenvalle A
Molecular therapy. Methods & clinical development 2020 Jun 12;17:1037-1047
Molecular therapy. Methods & clinical development 2020 Jun 12;17:1037-1047
A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology.
Birket MJ, Raibaud S, Lettieri M, Adamson AD, Letang V, Cervello P, Redon N, Ret G, Viale S, Wang B, Biton B, Guillemot JC, Mikol V, Leonard JP, Hanley NA, Orsini C, Itier JM
Stem cell reports 2019 Aug 13;13(2):380-393
Stem cell reports 2019 Aug 13;13(2):380-393
Mutant myocilin impacts sarcomere ultrastructure in mouse gastrocnemius muscle.
Lynch JM, Dolman AJ, Guo C, Dolan K, Xiang C, Reda S, Li B, Prasanna G
PloS one 2018;13(11):e0206801
PloS one 2018;13(11):e0206801
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.
Rouillon J, Poupiot J, Zocevic A, Amor F, Léger T, Garcia C, Camadro JM, Wong B, Pinilla R, Cosette J, Coenen-Stass AM, Mcclorey G, Roberts TC, Wood MJ, Servais L, Udd B, Voit T, Richard I, Svinartchouk F
Human molecular genetics 2015 Sep 1;24(17):4916-32
Human molecular genetics 2015 Sep 1;24(17):4916-32
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The MYOM3 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human MYOM3. This antibody recognizes human, mouse, rat antigen. The MYOM3 antibody has been validated for the following applications: ELISA, WB analysis.